Genetic Analyzer Market: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2016-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Global Genetic Analyzer Market by Product Type (Instruments, Consumables), by End-user (Diagnostics Centres, Drug Discovery, Research and Development, Others) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: , Tag:

Report

Description

Genetic Analyzer Market size is valued at USD 15.373 million in 2021 and is expected to reach USD 30.149 million by 2028, at a CAGR of 10.1% during the forecast period 2022-2028. Genetic tests are medical instruments that come in the form of kits or panels and are used to diagnose genetic illnesses in humans. Furthermore, blood samples from patients are collected throughout the procedure. These samples are then tested utilising test kits on laboratory machines. Furthermore, numerous sorts of tests are utilized to diagnose genetic abnormalities. For instance, some genetic tests include, predictive & presymptomatic testing, carrier testing, prenatal & newborn testing, diagnostic testing, pharmacogenomic testing, and others. Furthermore, these tests are used to diagnose medical conditions such as cancer, genetic disease, and cardiovascular disease. this report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, The global Genetic Analyzer Market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global Genetic Analyzer Market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities).

Genetic Analyzer Market

MARKET SUMMARY
-
10.1%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 10.1%
  • Largest Market– North-America
  • Fastest Growing Market– Europe

Genetic Analyzer Market

  • The global Genetic Analyzer Market report gives comprehensive outlook on Genetic Analyzer Market across the globe with special emphasis on key regions such as Asia Pacific, North America, Europe, Latin America, and Middle East and Africa.
  • The report on global Genetic Analyzer Market gives historical, current, and future market sizes (US$ Mn) on the basis of type, end-user and Region.
  • In May 2017, Thermo Fisher Scientific launched its Applied Biosystems SeqStudio Genetic Analyzer, a new capillary electrophoresis system which can be used for plasmid sequencing, species identification, human cell authentication and research in oncology
key players
  • Thermo Fisher Scientific Inc. (U.S.)
  • BioRad Laboratories (U.S.)
  • Abbott Laboratories (U.S.)
  • AutoGenomics Inc.( U.S.)
  • Celera Group (U.S.)
Genetic Analyzer Market

DRIVERS AND RESTRAINTS

The market for genetic analyzer systems is growing due to an increase in the number of chronic and genetic complications. Demand for gene function analysis is growing, which opens up new opportunities. The market for genetic analyzer systems has a lot of room for growth. Increased government investments in the creation of modern healthcare facilities, as well as the installation of technologically advanced automated genetic analyzer systems, are generating significant potential prospects for the genetic analyzer systems market. However, the shortage of expertise and advanced medical technology required to collect and interpret the genetic data generated by genetic analyzer systems is projected to limit the market’s expansion.


North-America got significant share

Genetic Analyzer Market

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

Genetic Analyzer Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content

1. Executive Summary
2. Global Genetic Analyzer Market Introduction
2.1. Global Genetic Analyzer Market – Taxonomy
2.2. Global Genetic Analyzer Market –Definitions
2.2.1. Product Type
2.2.2. End-User
3. Global Genetic Analyzer Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Genetic Analyzer Market Dynamics – Factors Impact Analysis
3.6. Global Genetic Analyzer Market – Regulations
3.6.1. US
3.6.2. Europe
3.6.3. Japan
4. Global Genetic Analyzer Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis
5. Global Genetic Analyzer Market, By Product Type, 2013 – 2017 and Forecast, 2018 – 2024
5.1. Instruments
5.1.1. DNA Microarrays
5.1.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.1.3. Market Opportunity Analysis
5.1.2. PCR
5.1.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.2.3. Market Opportunity Analysis
5.1.3. Next Generation Sequencing
5.1.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3.3. Market Opportunity Analysis
5.1.4. Serial Analysis of Gene Expression
5.1.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.1.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.4.3. Market Opportunity Analysis
5.1.5. Northern Blotting
5.1.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.1.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.5.3. Market Opportunity Analysis
5.2. Consumables
5.2.1. DNA Chips
5.2.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.1.3. Market Opportunity Analysis
5.2.2. Reagents
5.2.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.2.3. Market Opportunity Analysis
6. Global Genetic Analyzer Market Forecast, By End-User, 2013 – 2017 and Forecast, 2018 – 2024
6.1. Hospital Pharmacies
6.2. Diagnostics Centres
6.3. Drug Discovery
6.4. Research and Development
6.5. Others
6.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
7. Global Genetic Analyzer Market Forecast, By Region, 2013 – 2017 and Forecast, 2018 – 2024
7.1. North America
7.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Europe
7.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
7.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Latin America
7.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
7.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Global Genetic Analyzer Market – Opportunity Analysis Index, By Product Type, By End-User, and Region, 2018 – 2024
8. North America Genetic Analyzer Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
8.1. Product Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
8.1.1. Instruments
8.1.1.1. DNA Microarrays
8.1.1.2. PCR
8.1.1.3. Next Generation Sequencing
8.1.1.4. Serial Analysis of Gene Expression
8.1.1.5. Northern Blotting
8.1.2. Consumables
8.1.2.1. DNA Chips
8.1.2.2. Reagents
8.2. End-User Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
8.2.1. Diagnostics Centres
8.2.2. Drug Discovery
8.2.3. Research and Development
8.2.4. Others
8.3. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
8.3.1. US.
8.3.2. Canada
8.4. North America Genetic Analyzer Market – Opportunity Analysis Index, By Product Type, By End-User, and Country, 2018 – 2024
8.5. North America Genetic Analyzer Market Dynamics – Trends
9. Europe Genetic Analyzer Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
9.1. Product Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Instruments
9.1.1.1. DNA Microarrays
9.1.1.2. PCR
9.1.1.3. Next Generation Sequencing
9.1.1.4. Serial Analysis of Gene Expression
9.1.1.5. Northern Blotting
9.1.2. Consumables
9.1.2.1. DNA Chips
9.1.2.2. Reagents
9.2. End-User Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Diagnostics Centres
9.2.2. Drug Discovery
9.2.3. Research and Development
9.2.4. Others
9.3. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.3.1. Germany
9.3.2. UK
9.3.3. France
9.3.4. Spain
9.3.5. Italy
9.3.6. Russia
9.3.7. Poland
9.3.8. Rest of Europe
9.4. Europe Genetic Analyzer Market – Opportunity Analysis Index, By Product Type, By End-User, and Country, 2018 – 2024
9.5. Europe Genetic Analyzer Market Dynamics – Trends
10. Asia-Pacific Genetic Analyzer Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
10.1. Product Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Instruments
10.1.1.1. DNA Microarrays
10.1.1.2. PCR
10.1.1.3. Next Generation Sequencing
10.1.1.4. Serial Analysis of Gene Expression
10.1.1.5. Northern Blotting
10.1.2. Consumables
10.1.2.1. DNA Chips
10.1.2.2. Reagents
10.2. End-User Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Diagnostics Centres
10.2.2. Drug Discovery
10.2.3. Research and Development
10.2.4. Others
10.3. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
10.3.1. Japan
10.3.2. China
10.3.3. India
10.3.4. ASEAN
10.3.5. Australia & New Zealand
10.3.6. Rest of Asia-Pacific
10.4. Asia-Pacific Genetic Analyzer Market – Opportunity Analysis Index, By Product Type, By End-User, and Country, 2018 – 2024
10.5. Asia-Pacific Genetic Analyzer Market Dynamics – Trends
11. Latin America Genetic Analyzer Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
11.1. Product Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Instruments
11.1.1.1. DNA Microarrays
11.1.1.2. PCR
11.1.1.3. Next Generation Sequencing
11.1.1.4. Serial Analysis of Gene Expression
11.1.1.5. Northern Blotting
11.1.2. Consumables
11.1.2.1. DNA Chips
11.1.2.2. Reagents
11.2. End-User Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Diagnostics Centres
11.2.2. Drug Discovery
11.2.3. Research and Development
11.2.4. Others
11.3. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Argentina
11.3.4. Venezuela
11.3.5. Rest of Latin America
11.4. Latin America Genetic Analyzer Market – Opportunity Analysis Index, By Product Type, By End-User, and Country, 2018 – 2024
11.5. Latin America Genetic Analyzer Market Dynamics – Trends
12. Middle East and Africa Genetic Analyzer Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
12.1. Product Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Instruments
12.1.1.1. DNA Microarrays
12.1.1.2. PCR
12.1.1.3. Next Generation Sequencing
12.1.1.4. Serial Analysis of Gene Expression
12.1.1.5. Northern Blotting
12.1.2. Consumables
12.1.2.1. DNA Chips
12.1.2.2. Reagents
12.2. End-User Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Diagnostics Centres
12.2.2. Drug Discovery
12.2.3. Research and Development
12.2.4. Others
12.3. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.3.1. Gulf Cooperation Council (GCC) Countries
12.3.2. Israel
12.3.3. South Africa
12.3.4. Rest of MEA
12.4. MEA Genetic Analyzer Market – Opportunity Analysis Index, By Product Type, By End-User, and Country, 2018 – 2024
12.5. MEA Genetic Analyzer Market Dynamics – Trends
13. Competition Landscape
13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, Product Type & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
13.2.1. Thermo Fisher Scientific Inc. (U.S.)
13.2.2. BioRad Laboratories (U.S.)
13.2.3. Abbott Laboratories (U.S.)
13.2.4. AutoGenomics Inc. (U.S.)
13.2.5. Celera Group (U.S.)
13.2.6. PerkinElmer Inc. (U.S.)
13.2.7. Quest Diagnostics Inc. (U.S.)
13.2.8. ELITech Group (U.S.)
13.2.9. Applied Biosystems Inc. ( U.S.)
13.2.10. F. Hoffmann-La Roche AG (Switzerland)
13.2.11. Transgenomic Inc.( U.S.)
14. Research Methodology
15. Key Assumptions and Acronyms


Report

Company Profile

  • Thermo Fisher Scientific Inc. (U.S.)
  • BioRad Laboratories (U.S.)
  • Abbott Laboratories (U.S.)
  • AutoGenomics Inc.( U.S.)
  • Celera Group (U.S.)
  • PerkinElmer Inc.( U.S.)
  • Quest Diagnostics Inc.( U.S.)
  • ELITech Group (U.S.)
  • Applied Biosystems Inc.( U.S.)
  • F. Hoffmann-La Roche AG (Switzerland)
  • Transgenomic Inc.( U.S.)

Description

Genetic Analyzer Market size is valued at USD 15.373 million in 2021 and is expected to reach USD 30.149 million by 2028, at a CAGR of 10.1% during the forecast period 2022-2028. Genetic tests are medical instruments that come in the form of kits or panels and are used to diagnose genetic illnesses in humans. Furthermore, blood samples from patients are collected throughout the procedure. These samples are then tested utilising test kits on laboratory machines. Furthermore, numerous sorts of tests are utilized to diagnose genetic abnormalities. For instance, some genetic tests include, predictive & presymptomatic testing, carrier testing, prenatal & newborn testing, diagnostic testing, pharmacogenomic testing, and others. Furthermore, these tests are used to diagnose medical conditions such as cancer, genetic disease, and cardiovascular disease. this report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, The global Genetic Analyzer Market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global Genetic Analyzer Market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities).

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX